Teva Launches Generic for Flector Pain Patch

Teva Pharmaceutical Industries Ltd. has announced the launch of an authorized generic form of the Flector patch in the U.S. The diclofenac epolamine topical patch, 1.3%, is a nonsteroidal anti-inflammatory drug, or NSAID, indicated as a topical treatment for acute pain due to minor strains, sprains and contusions. The Flector patch ranked No. 14 in terms of workers’ comp drug spend in 2016 and 2017, according to a report from Optum’s workers’ compensation division. Pfizer produces the brand-name Flector patch. It had annual sales of $123 million in the U.S., Teva said, cit...